Conference - New York, United States
A primary goal of the meeting is to provide a forum where medical scientists from academia can interact with scientists from the biopharmaceutical industry, thus forging a community of academic and industry researchers who recognize that they have much to learn from each other. Rational drug discovery for neurodegenerative diseases has begun to yield compounds and treatments that are now entering clinical settings. For human studies utilizing these compounds and treatments to be maximally informative, it is crucial that scientists from academia and industry meet regularly to exchange data and ideas.
Session Topics:
1) Prion-Like Neurodegeneration: Initiation and Disease Spread
2) Risk Factors and Co-Morbidities: Aging, Biomarkers, and Genetics
3) RNA Metabolism in Neurodegenerative Disease
4) Glial Biology: New Targets for Therapy in Neurodegeneration
5) Immune and Small-Molecule Therapy for Alzheimer's and Parkinson's Diseases
6) Gene Inactivation Strategies
(Courtesy of http://meetings.cshl.edu/)
Wednesday, November 28, 2012 - Saturday, December 1, 2012
Cold Spring Harbor Laboratory
New York, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
